| Product Name | MARC2 Antibody - C-terminal region |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | The immunogen for Anti-MARC2 antibody is: synthetic peptide directed towards the C-terminal region of Human MARC2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | MARC2 |
|---|---|
| Gene Synonyms | MOSC2 RP11-270A6.1 |
| Gene Summary | As a component of the benzamidoxime prodrug-converting complex, MARC2 is required to reduce N-hydroxylated prodrugs, such as benzamidoxime. It also able to reduce N(omega)-hydroxy-L-arginine (NOHA) and N(omega)-hydroxy-N(delta)-methyl-L-arginine (NHAM) into L-arginine and N(delta)-methyl-L-arginine. |
| Alternative Names | MOSC2 RP11-270A6.1 |
| Molecular Weight(MW) | 38kDa |
| Sequence | 335 amino acids |
| Form | Liquid |
|---|---|
| Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
